Innate Pharma: Pipeline Optionality Favors Speculative Bulls At These Levels

Innate Pharma S.A. (IPHA) is a French clinical-stage oncology company focused on developing antibody-based therapies that use natural killer cells to target tumors. The main investment highlights are the early clinical results of its IPH4502 candidate, plans This article was written by Myriam Alvarez 3.54K Followers Follow My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio University, Athens, OH, USA, a graduate degree in Business Management from Universidad Andina Simon Bolivar, Quito, Ecuador, and the Ph.D. degree in computer applications from the University of Alicante, Spain.